ArticleBMC neurology2026
Association of prognostic nutritional index with mortality in patients with sepsis-associated delirium: a retrospective MIMIC-IV study.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundA concerning sign of severe brain dysfunction, sepsis-associated delirium (SAD) is associated with poor clinical outcomes. The prognostic value of the Prognostic Nutritional Index (PNI) for patients with SAD is unclear.
objectiveTo determine the association between PNI and all-cause mortality at 90, 180, and 360 days in SAD patients.
methodsWe classified SAD patients into low-PNI and high-PNI groups based on PNI. We then used Kaplan-Meier (KM) survival analysis, multivariate Cox regression, restricted cubic spline (RCS) models, inverse probability of treatment weighting (IPTW), and subgroup analysis to evaluate the association between these groups and all-cause mortality at 90, 180, and 360 days. A receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive ability of PNI.
resultsAmong 2,160 patients, the low PNI group had significantly higher mortality than the high PNI group at 90 days (51.9% vs. 33.5%), 180 days (56.4% vs. 37.1%), and 360 days (60.6% vs. 41.5%). After adjustment, Cox regression showed low PNI was associated with a 1.55-fold higher 90-day mortality (95% CI: 1.34-1.79, p < 0.001). A restricted cubic spline model revealed a nonlinear PNI-outcome relationship. These results were robust in IPTW and subgroup analyses, and ROC analysis demonstrated predictive performance comparable to that of SOFA and albumin.
conclusionThe PNI is a simple, useful, and easily accessible tool that can help identify patients with SAD who are at increased risk of adverse outcomes at an early stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.